Skip to main content

Main menu

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Early View
  • Archive
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

Table of Contents

01 July 2018; volume 4, issue 3

Editorial

  • Open Access
    The WHO–ERS Smoking Cessation Training Project: the first year of experience
    Dongbo Fu, Christina Gratziou, Carlos Jiménez-Ruiz, Marine Faure, Brian Ward, Sofia Ravara, Vinayak Mohan Prasad, Kristina Mauer-Stender, Jagdish Kaur, Angela Ciobanu, Syed Mahfuzul Huq, Paraskevi Katsaounou
    ERJ Open Res 4: 00070-2018; DOI: 10.1183/23120541.00070-2018 Published 31 July 2018

Study protocol

  • Open Access
    Understanding asthma phenotypes: the World Asthma Phenotypes (WASP) international collaboration
    Lucy Pembrey, Mauricio L. Barreto, Jeroen Douwes, Philip Cooper, John Henderson, Harriet Mpairwe, Cristina Ardura-Garcia, Martha Chico, Collin Brooks, Alvaro A. Cruz, Alison M. Elliott, Camila A. Figueiredo, Sinéad M. Langan, Beatrice Nassanga, Susan Ring, Laura Rodrigues, Neil Pearce
    ERJ Open Res 4: 00013-2018; DOI: 10.1183/23120541.00013-2018 Published 22 August 2018

Original articles

  • COPD

    • Open Access
      Microbial and host immune factors as drivers of COPD
      Moana Mika, Izabela Nita, Laura Morf, Weihong Qi, Seraina Beyeler, Eric Bernasconi, Benjamin J. Marsland, Sebastian R. Ott, Christophe von Garnier, Markus Hilty
      ERJ Open Res 4: 00015-2018; DOI: 10.1183/23120541.00015-2018 Published 3 July 2018
    • Open Access
      Circulating eosinophil levels do not predict severe exacerbations in COPD: a retrospective study
      Yochai Adir, Omar Hakrush, Michal Shteinberg, Sonia Schneer, Alvar Agusti
      ERJ Open Res 4: 00022-2018; DOI: 10.1183/23120541.00022-2018 Published 3 August 2018
    • Open Access
      Determinants and outcomes of change in physical activity in COPD
      Ana Kantorowski, Emily S. Wan, Diana Homsy, Reema Kadri, Caroline R. Richardson, Marilyn L. Moy
      ERJ Open Res 4: 00054-2018; DOI: 10.1183/23120541.00054-2018 Published 3 August 2018
  • Cystic fibrosis

    • Open Access
      Comparison of different analysis algorithms to calculate multiple-breath washout outcomes
      Pinelopi Anagnostopoulou, Nadja Kranz, Jeremias Wolfensberger, Marisa Guidi, Sylvia Nyilas, Cordula Koerner-Rettberg, Sophie Yammine, Florian Singer, Philipp Latzin
      ERJ Open Res 4: 00021-2017; DOI: 10.1183/23120541.00021-2017 Published 13 July 2018
  • Tuberculosis

    • Open Access
      Post-migration follow-up programme for migrants at increased risk of developing tuberculosis: a cohort study
      Nishta Kaushik, Chris Lowbridge, Gabriella Scandurra, Claudia C. Dobler
      ERJ Open Res 4: 00008-2018; DOI: 10.1183/23120541.00008-2018 Published 13 July 2018
  • Biomarkers

    • Open Access
      Altered Fc galactosylation in IgG4 is a potential serum marker for chronic lung disease
      Tina Heyder, Emil Wiklundh, Anders Eklund, Anna James, Sven-Erik Dahlén, Johan Grunewald, Roman A. Zubarev, Susanna L. Lundström
      ERJ Open Res 4: 00033-2018; DOI: 10.1183/23120541.00033-2018 Published 31 July 2018
  • Lung cancer

    • Open Access
      Surgically treated lung cancer patients: do they all smoke and would they all have been detected with lung cancer screening?
      Tanel Laisaar, Bruno Sarana, Indrek Benno, Kaja-Triin Laisaar
      ERJ Open Res 4: 00001-2018; DOI: 10.1183/23120541.00001-2018 Published 3 August 2018
    • Open Access
      New drugs in thoracic oncology: needs and knowledge – an online ERS Lung Cancer Assembly survey
      Thierry Berghmans, Matthew Evison, Torsten Gerriet Blum, Nir Peled, Jacques Cadranel
      ERJ Open Res 4: 00040-2018; DOI: 10.1183/23120541.00040-2018 Published 3 September 2018
  • Pulmonary vascular disease

    • Open Access
      Metformin added to bosentan therapy in patients with pulmonary arterial hypertension associated with congenital heart defects: a pilot study
      Shutan Liao, Dongsheng Li, Zheng Hui, Craig S. McLachlan, Yang Zhang
      ERJ Open Res 4: 00060-2018; DOI: 10.1183/23120541.00060-2018 Published 22 August 2018
  • Interstitial lung disease

    • Open Access
      Mechanisms of exercise limitation in patients with chronic hypersensitivity pneumonitis
      Olívia Meira Dias, Bruno Guedes Baldi, Jeferson George Ferreira, Letícia Zumpano Cardenas, Francesca Pennati, Caterina Salito, Carlos Roberto Ribeiro Carvalho, Andrea Aliverti, André Luis Pereira de Albuquerque
      ERJ Open Res 4: 00043-2018; DOI: 10.1183/23120541.00043-2018 Published 22 August 2018

Original research letters

  • Open Access
    Prevention of aerosol isolation of nontuberculous mycobacterium from the patient's bathroom
    Kozo Morimoto, Akio Aono, Yoshiro Murase, Tsuyoshi Sekizuka, Atsuyuki Kurashima, Akiko Takaki, Yuka Sasaki, Yuriko Igarashi, Kinuyo Chikamatsu, Hajime Goto, Hiroyuki Yamada, Makoto Kuroda, Satoshi Mitarai
    ERJ Open Res 4: 00150-2017; DOI: 10.1183/23120541.00150-2017 Published 3 July 2018
  • Open Access
    Interstitial lung abnormalities and physical function
    Gisli Thor Axelsson, Rachel K. Putman, Ezra R. Miller, Tetsuro Araki, Sigurdur Sigurdsson, Elias F. Gudmundsson, Gudny Eiríksdottír, Kristin Siggeirsdottir, Thor Aspelund, Lenore J. Launer, Tamara B. Harris, Hiroto Hatabu, Vilmundur Gudnason, Gary M. Hunninghake, Gunnar Gudmundsson
    ERJ Open Res 4: 00057-2018; DOI: 10.1183/23120541.00057-2018 Published 3 September 2018
  • Open Access
    Use of adjunct cardiovascular therapy in patients hospitalised for acute exacerbations of COPD
    Sara Roversi, Roberto Tonelli, Bianca Beghè, Federico Banchelli, Roberto D'Amico, Mario Malerba, Leonardo M. Fabbri, Enrico M. Clini
    ERJ Open Res 4: 00087-2018; DOI: 10.1183/23120541.00087-2018 Published 12 September 2018

Author corrections

  • Open Access
    “Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons” Iwona Pranke, Laure Bidou, Natacha Martin, Sandra Blanchet, Aurélie Hatton, Sabrina Karri, David Cornu, Bruno Costes, Benoit Chevalier, Danielle Tondelier, Emmanuelle Girodon, Matthieu Coupet, Aleksander Edelman, Pascale Fanen, Olivier Namy, Isabelle Sermet-Gaudelus and Alexandre Hinzpeter. ERJ Open Res 2018; 4: 00080-2017.
    ERJ Open Res 4: 00080-2017-AUT; DOI: 10.1183/23120541.50080-2017 Published 13 July 2018
  • Open Access
    “A stepwise composite echocardiographic score predicts severe pulmonary hypertension in patients with interstitial lung disease” Simon Bax, Charlene Bredy, Aleksander Kempny, Konstantinos Dimopoulos, Anand Devaraj, Simon Walsh, Joseph Jacob, Arjun Nair, Maria Kokosi, Gregory Keir, Vasileios Kouranos, Peter M. George, Colm McCabe, Michael Wilde, Athol Wells, Wei Li, Stephen John Wort and Laura C. Price. ERJ Open Res 2018; 4: 00124-2017.
    ERJ Open Res 4: 00124-2017-AUT; DOI: 10.1183/23120541.50124-2017 Published 31 July 2018
Back to top
PreviousNext
ERJ Open Research: 4 (3)
  • Table of Contents
  • Index by author

Search Within This Issue

Jump to

  • Editorial
  • Study protocol
  • Original articles
    • COPD
    • Cystic fibrosis
    • Tuberculosis
    • Biomarkers
    • Lung cancer
    • Pulmonary vascular disease
    • Interstitial lung disease
  • Original research letters
  • Author corrections
Manage Table of content Alerts
  • Most Read
  • Twitter
Loading
  • Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome?
  • A potential harmful effect of dexamethasone in non-severe COVID-19: results from the COPPER-pilot study
  • Impact of N-acetyl-l-cysteine on SARS-CoV-2 pneumonia and its sequelae: results from a large cohort study
  • IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette
  • The safety of cardioselective β1-blockers in asthma: literature review and search of global pharmacovigilance safety reports
More...

Navigate

  • Home
  • Current issue
  • Archive

About ERJ Open Research

  • Editorial board
  • Journal information
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Online ISSN: 2312-0541

Copyright © 2023 by the European Respiratory Society